Cargando…

Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation

Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rewiuk, Krzysztof, Grodzicki, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609353/
https://www.ncbi.nlm.nih.gov/pubmed/26504794
http://dx.doi.org/10.1155/2015/259843
_version_ 1782395794960154624
author Rewiuk, Krzysztof
Grodzicki, Tomasz
author_facet Rewiuk, Krzysztof
Grodzicki, Tomasz
author_sort Rewiuk, Krzysztof
collection PubMed
description Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset of AF. Methods and Results. We included 60 patients with acute onset of AF, candidates for pharmacological cardioversion. The presence of cardiovascular comorbidities was connected with higher concentration of OPG and lower level of TRAIL right from the first hours of AF paroxysm. The initial TRAIL level correlated also positively with left ventricle ejection fraction and negatively with left atrium diameter. We found subsequent increase of OPG in subgroups selected on the basis of CHA(2)DS(2)-VASc scoring. Although basal concentrations of studied markers did not allow prediction of the restoration of sinus rhythm, we observed important increase of TRAIL concentration in subgroup with sinus rhythm maintenance (94.11 ± 29.46 versus 111.39 ± 30.23 pg/mL; p = 0.002). Conclusions. OPG and TRAIL are associated with the underlying cardiovascular damage in AF, but their balance is modulated by the fact of sinus rhythm restoration. Determining the suitability of OPG and TRAIL as predictive markers in AF requires further prospective studies.
format Online
Article
Text
id pubmed-4609353
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46093532015-10-26 Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation Rewiuk, Krzysztof Grodzicki, Tomasz Biomed Res Int Research Article Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset of AF. Methods and Results. We included 60 patients with acute onset of AF, candidates for pharmacological cardioversion. The presence of cardiovascular comorbidities was connected with higher concentration of OPG and lower level of TRAIL right from the first hours of AF paroxysm. The initial TRAIL level correlated also positively with left ventricle ejection fraction and negatively with left atrium diameter. We found subsequent increase of OPG in subgroups selected on the basis of CHA(2)DS(2)-VASc scoring. Although basal concentrations of studied markers did not allow prediction of the restoration of sinus rhythm, we observed important increase of TRAIL concentration in subgroup with sinus rhythm maintenance (94.11 ± 29.46 versus 111.39 ± 30.23 pg/mL; p = 0.002). Conclusions. OPG and TRAIL are associated with the underlying cardiovascular damage in AF, but their balance is modulated by the fact of sinus rhythm restoration. Determining the suitability of OPG and TRAIL as predictive markers in AF requires further prospective studies. Hindawi Publishing Corporation 2015 2015-10-04 /pmc/articles/PMC4609353/ /pubmed/26504794 http://dx.doi.org/10.1155/2015/259843 Text en Copyright © 2015 K. Rewiuk and T. Grodzicki. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Rewiuk, Krzysztof
Grodzicki, Tomasz
Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
title Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
title_full Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
title_fullStr Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
title_full_unstemmed Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
title_short Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
title_sort osteoprotegerin and trail in acute onset of atrial fibrillation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609353/
https://www.ncbi.nlm.nih.gov/pubmed/26504794
http://dx.doi.org/10.1155/2015/259843
work_keys_str_mv AT rewiukkrzysztof osteoprotegerinandtrailinacuteonsetofatrialfibrillation
AT grodzickitomasz osteoprotegerinandtrailinacuteonsetofatrialfibrillation